DJO Global develops, manufactures, and distributes a wide array of medical devices focused on rehabilitation, pain management, and physical therapy. The company operates through four segments: Bracing and Vascular, Recovery Sciences, Surgical Implant, and International. Its product offerings include rigid knee braces, orthopedic soft goods, cold therapy products, vascular therapy systems, therapeutic shoes, and compression therapy products, marketed under various brands such as DonJoy, ProCare, and Aircast. Additionally, DJO Global provides bone growth stimulators, clinical electrotherapy devices, and other physical therapy equipment tailored for use by healthcare professionals, including orthopedic specialists, spine surgeons, and physical therapists. The company also has a surgical division that offers reconstructive joint products for the hip, knee, and shoulder. With a commitment to addressing the continuum of patient care, DJO Global’s devices facilitate injury prevention and rehabilitation, enabling individuals to regain their natural motion. The company distributes its products through direct sales representatives and a network of dealers and distributors across various global markets. Founded in 1978 and based in Vista, California, DJO Global is a subsidiary of Colfax Corporation.
Senior Vice President of Global Business Transformation and Delivery Leader
6 past transactions
Novastep
Acquisition in 2023
Novastep is a global medical device company based in Englewood Cliffs, New Jersey, specializing in the design, development, and marketing of products aimed at treating conditions affecting the bones, joints, and soft tissues of the foot and ankle. The company is dedicated to delivering innovative technologies and medical education programs to support surgeons in their clinical practices. Novastep collaborates closely with surgeon inventors and customers to identify and address the challenges they encounter, continuously focusing on creating new and improved devices tailored for the foot and ankle market.
Mathys
Acquisition in 2021
Mathys develops, produces and distributes products for artificial joint replacement, synthetic bone graft substitute and sports medicine.
MedShape
Acquisition in 2021
MedShape is a privately held medical device company founded in 2005 based on a portfolio of proprietary surgical solutions that use its patented adaptive shape memory healing technologies to address the increasing demand for improved joint fusion, sports medicine, and musculoskeletal trauma products. MedShape® has enjoyed long-term support from Hills Capital Management, the Georgia Research Alliance (GRA), the National Science Foundation (NSF), the National Institutes of Health (NIH), and In-Q-Tel.
Trilliant Surgical
Acquisition in 2021
Trilliant Surgical, LLC, based in Houston, Texas, specializes in the creation and manufacture of medical devices aimed at small bone orthopedic correction. The company provides a variety of small bone implants designed for both elective and trauma procedures related to the foot and ankle. Its product offerings include cannulated screw fixation systems, various plating options, bunion and hammer toe correction devices, subtalar implants, staple fixation systems, hemi toe implants, and biologics for diverse foot and ankle surgeries. Founded in 2007, Trilliant Surgical is committed to the innovation of podiatric implants and surgical instruments, focusing on design, development, and distribution to enhance surgical outcomes and improve practice efficiency for podiatrists and orthopedic surgeons.
LiteCure
Acquisition in 2020
LiteCure, LLC is a manufacturer of medical devices that serves both medical and veterinary healthcare professionals. Established in 2006 and based in New Castle, Delaware, the company specializes in advanced laser technology, offering products such as deep tissue therapy lasers for pain management and companion laser therapies for pets. LiteCure operates as a subsidiary of DJO Global, Inc. and includes divisions like LiteCure Medical and Companion Therapy. The company is committed to quality, with its products being FDA cleared and manufactured under strict quality control systems compliant with ISO-9001 and ISO-13485 standards. By integrating physics, laser science, and engineering, LiteCure provides innovative solutions aimed at improving health outcomes in both human and veterinary medicine.
Iomed
Acquisition in 2007
IOMED, Inc.develops, manufactures and commercializes controllable drug delivery systems using iontophoretic technology. Iontophoresis is a non-invasive method of enhancing and controlling the transport of water-soluble ionic drugs into and through the skin using a low level electrical current. The Company's proprietary iontophoretic drug delivery systems allow rapid onset and cessation of therapeutic action, as well as programmable dose control. The systems enable caregivers and patients to control the onset of drug effectiveness and maintain, reduce or cease drug administration once a desired therapeutic effect is observed. The programming feature also enables caregivers to customize dosing patterns to meet each patient's specific needs. The Company is developing systems designed to enable patient monitoring and control. The flexibility of the Company's proprietary systems provides therapeutic control not possible with many alternative drug delivery methods, including oral tablets and capsules, injections, inhalants and passive transdermal patches. The Company's systems may also increase bioavailability, safety and patient comfort.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.